Quest Diagnostics (DGX) Depreciation and Depletion (2009 - 2026)

Quest Diagnostics has reported Depreciation and Depletion for 18 years, with the latest figure at $108.0 million in Q2 2026.

• Quarterly Depreciation and Depletion rose 3.85% year-over-year to $108.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $429.0 million (up 8.33% YoY) and the FY2025 annual result came in at $416.0 million, up 13.66% from the prior year.
• Depreciation and Depletion fell to $108.0 million in Q2 2026 per DGX's latest filing, from $110.0 million in the prior quarter.
• Over five years, Depreciation and Depletion peaked at $110.0 million in Q1 2026 and troughed at $77.0 million in Q4 2022.
• A 5-year average of $91.6 million and a median of $87.5 million in 2024 frame the typical range for Depreciation and Depletion.
• The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion decreased 3.75% in 2022, then gained 19.51% in 2024.
• Over 5 years, Depreciation and Depletion stood at $77.0 million in 2022, then advanced by 6.49% to $82.0 million in 2023, then rose by 19.51% to $98.0 million in 2024, then climbed by 10.2% to $108.0 million in 2025, then changed by 0.0% to $108.0 million in 2026.
• According to Business Quant data, Depreciation and Depletion over the past three periods registered $108.0 million, $110.0 million, and $108.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.